US Bancorp
ETRM

US Bancorp’s EnteroMedics Inc. ETRM Stock Holding History

US Bancorp’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1
Closed – – 3877
2015
Q3 		$0 Hold
1
– – ﹤0.01% 3857
2015
Q2 		$1K Hold
1
– – ﹤0.01% 3555
2015
Q1 		$1K Hold
1
– – ﹤0.01% 3545
2014
Q4 		$1K Hold
1
– – ﹤0.01% 3516
2014
Q3 		$1K Hold
1
– – ﹤0.01% 3490
2014
Q2 		$2K Buy
+1
New +$1.87K ﹤0.01% 3412

Other funds holding ETRM

PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

US Bancorp's ETRM Position: Q4 2015 in Review

US Bancorp sold out of EnteroMedics Inc. (ETRM) in Q4 2015, closing a stake of 1 share.

US Bancorp first reported a position in ETRM in Q2 2014 and held it in 6 quarters. The position peaked at $2K in Q2 2014. 33 funds tracked by Wall St. Rank hold ETRM as of Q4 2015.

  • US Bancorp reported no remaining EnteroMedics Inc. position as of Q4 2015 after selling out during the quarter.
  • US Bancorp sold 1 EnteroMedics Inc. share in Q4 2015.
  • US Bancorp first reported a position in EnteroMedics Inc. in Q2 2014 and held it in 6 quarters.
  • US Bancorp's EnteroMedics Inc. position peaked at $2K in Q2 2014.
  • 33 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2015.

Based on US Bancorp's 13F filing for Q4 2015, filed 10 Feb 2016.